Hemanth J. Varghese

Chief Strategy Officer · Viatris

Pharmaceuticals

Hemanth J. Varghese is chief strategy officer of Viatris, which he joined in April 2025. His earlier healthcare career combines corporate development, international pharmaceuticals and operating leadership in medical technology.

Last reviewed: Oct 21, 2026

Hemanth J. Varghese

Chief Strategy Officer
Viatris

Last Reviewed: October 21, 2026

Executive Summary

Hemanth J. Varghese is chief strategy officer of Viatris, which he joined in April 2025. His earlier healthcare career combines corporate development, international pharmaceuticals and operating leadership in medical technology.

Career Highlights

  • Joined Viatris as chief strategy officer in April 2025.
  • Previously served as president and COO of Venus Concept.
  • Held strategy and operating roles at HLS Therapeutics, Endo and other healthcare businesses.

Professional Journey

Varghese developed corporate development experience at Biovail and subsequently held roles of increasing responsibility at Valeant Pharmaceuticals and Bausch & Lomb. At Endo International, his assignments included executive vice president of corporate development and strategy and president of International Pharmaceuticals.

He later served as senior vice president of strategy and operations at HLS Therapeutics and as president and chief operating officer of Venus Concept, a medical aesthetic technology company. Those roles combined transaction work with operating and organizational responsibilities.

Viatris announced his arrival as chief strategy officer in April 2025, adding him to its executive leadership team. His background spans portfolio development, business development and transformation in multinational healthcare companies. He holds undergraduate and doctoral qualifications from the University of Western Ontario and is a Chartered Financial Analyst.

Education

  • Bachelor’s degree — University of Western Ontario
  • Doctor of Philosophy in Medical Biophysics — University of Western Ontario